Medical Cannabis Lowers ER Visits and Boosts QoL

A recent study¹ published in July 2025 delivers yet another data-backed confirmation of something millions of patients have long known – medical cannabis can significantly improve life for people living with chronic pain. Conducted by researchers from Leafwell and George Mason University, the study found that cannabis-exposed patients experienced fewer emergency room visits, reduced urgent care use, and reported notably better quality of life compared to those who did not use cannabis.

Using real-world data from over 5,000 patients across 36 U.S. states, the researchers applied advanced machine learning techniques to evaluate the relationship between medical cannabis use and healthcare utilization. The results are not only statistically significant, but they’re also practically and politically urgent.

Key Findings from the Study

• Medical cannabis users had a 27% lower risk of urgent care visits
• They had nearly 33% lower odds of visiting the emergency room
• Users reported 3.5 fewer unhealthy days per month, indicating improved daily functioning
• Quality of life (QoL) improved by over 18%, as measured by the CDC’s HRQOL-4 index
• Hospitalizations trended lower, though not statistically significant in this analysis

These findings suggest that cannabis is not just a symptom-soother, but it may meaningfully reduce the burden on the healthcare system by helping patients better manage their conditions without the need for acute interventions.

What Chronic Pain Patients Report About Cannabis Relief

If you live with chronic pain, these findings are likely not shocking; they’re validating. For decades, patients have reported that cannabis helps them function, rest, and regain control over their lives in ways that pharmaceuticals often fail to deliver. And while research has uncovered a large number of therapeutic benefits cannabis offers, the discrepancy between public knowledge and public policy (PPHC ) remains vast.

This study provides empirical evidence for what cannabis advocates, clinicians, and patients have been saying for years: Cannabis improves quality of life and can reduce dependence on costly, often overburdened acute care systems.

So why, in 2025, do we still treat access to cannabis as a privilege, rather than a right, especially when it so clearly works?

Why Is Cannabis Still Inaccessible for So Many?

Despite medical cannabis being legal in the majority of U.S. states and numerous countries around the world, millions still lack affordable, stigma-free access due to outdated federal laws, insurance limitations, and deep-rooted cultural resistance. Cannabis is still classified as a Schedule I substance federally in the United States: a category reserved for drugs with no accepted medical use, despite mountains of evidence proving the opposite.

This contradiction not only undermines science but also directly harms patients. It blocks insurance coverage, limits physician guidance, deters clinical research, and perpetuates disparities in access, particularly among low-income, rural, and marginalized communities.

Moving Beyond “Does It Work?” to “Why Can’t Everyone Access It?”

The medical cannabis debate should no longer center around whether it works; we’ve moved past that. Dozens of peer-reviewed studies, like this one, consistently show benefits for chronic pain, PTSD, epilepsy, and more. The real question we must now ask is: Why is cannabis not available to everyone who needs it?

This latest study adds to a growing body of research demonstrating that cannabis is not just an alternative to pain medication, but it can also reduce system-wide costs. Reduced emergency and urgent care visits, along with better patient-reported health outcomes, should be enough to push policy forward.

Yet, we remain stuck in a policy paradox with state-level progress clashing against federal inaction, and insurance companies unwilling to cover even doctor-recommended cannabis treatments.

Advocacy Must Be Rooted in the Science and the Patients

For advocacy to work, it must be anchored in both data and humanity. Studies like this bring academic credibility to what has long been treated as anecdote; the fact that cannabis provides real relief. But we cannot stop at publishing data. There must be policy reform, insurance inclusion, and education for providers. There must be advocacy for a medical system that prioritizes outcomes over stigma.

This is especially important for those with chronic pain who’ve been failed by traditional medicine, often passed from prescription to prescription, never fully achieving relief. For them, medical cannabis represents more than just a treatment. It’s freedom.

Final Thoughts: The Time for Proof Has Passed

This study should be a call to action, not for further justification, but for equitable access and compassionate reform. Medical cannabis clearly helps chronic pain patients manage their symptoms, reduce ER visits, and improve daily life. The data is in. The patients are waiting.

We must now move from asking “Can cannabis help?” to declaring “Everyone who needs it deserves access.”

Because when the evidence is this strong, withholding access is not just poor policy, it’s inhumane.

Studies Referenced:

^{1. Doucette, M. L., Fisher, E., Chin, J., & Kitsantas, P. (2025). Medical Cannabis Use and Healthcare Utilization Among Patients with Chronic Pain: A Causal Inference Analysis Using TMLE. Pharmacy, 13(4), 96. https://doi.org/10.3390/pharmacy13040096}